Phase I safety and pharmacokinetics trial of MRX I in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2012
At a glance
- Drugs Contezolid (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant enterococcal infections
- Focus Adverse reactions; Pharmacokinetics
- 24 Apr 2012 Planned initiation date changed to 1 Dec 2010.
- 24 Apr 2012 Status changed from planning to completed.
- 25 Mar 2010 New trial record